Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Hopewell S. et al, (2025), Ewha Medical Journal

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45

Clustering of Multimorbidity and Social Care Needs: 10-year all-cause mortality in a cohort study of more than 7 million people

Islam N. et al, (2025)

CONSORT 2025 statement: updated guideline for reporting randomised trials

Hopewell S. et al, (2025), The Lancet, 405, 1633 - 1640

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ (Clinical research ed.), 389

CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.

Hopewell S. et al, (2025), JAMA

CONSORT 2025 statement: updated guideline for reporting randomized trials.

Hopewell S. et al, (2025), Nature medicine

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ (Clinical research ed.), 389

CONSORT 2025 statement: Updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), PLoS medicine, 22

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.

Hróbjartsson A. et al, (2025), BMJ (Clinical research ed.), 389

SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials.

Chan A-W. et al, (2025), JAMA

SPIRIT 2025 statement: updated guideline for protocols of randomized trials.

Chan A-W. et al, (2025), Nature medicine

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), BMJ (Clinical research ed.), 389

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), PLoS medicine, 22

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

Dennis JM. et al, (2025), Lancet (London, England), 405, 701 - 714

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.

Sammons E. et al, (2025), BMJ open, 15

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

Dennis JM. et al, (2025), LANCET, 405, 701 - 714

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study

Cardoso P. et al, (2025), Diabetes Obesity and Metabolism

SPIRIT 2025 statement: updated guideline for protocols of randomised trials

Chan A-W. et al, (2025), LANCET, 405, E19 - E27

Value of using artificial intelligence derived clusters by health and social care need in primary care: A qualitative interview study with patients living with multiple long-term conditions, carers and health care professionals.

Holt S. et al, (2025), Journal of multimorbidity and comorbidity, 15

Load More